Jonathan W. Friedberg
Editor-in-Chief at Journal of Global Oncology
Lymphoma expert. Director of @WilmotCancer Rochester NY. Editor-in-Chief, Journal of Clinical Oncology @asco_pubs. Tweets and opinions are my own.
Articles
-
1 month ago |
brnw.ch | Adam Olszewski |Michael LeBlanc |Michael Leblanc |Jonathan W. Friedberg
BackgroundFollicular lymphoma (FL) is the second most common non-Hodgkin's lymphoma and currently considered incurable with standard therapies.1 The majority of patients present with advanced disease, and many of them are asymptomatic at diagnosis.
-
1 month ago |
ascopubs.org | Adam Olszewski |Michael LeBlanc |Michael Leblanc |Jonathan W. Friedberg
The following protocol information is provided solely to describe how the authors conducted the research underlying this article. The information provided may not reflect the complete protocol or any previous amendments or modifications. As described in the Information for Contributors, JCO OA requests only specific elements of the most recent version of the protocol.
-
Dec 15, 2023 |
ascopubs.org | Eileen M. O'Reilly |Andrew H. Ko |Jonathan W. Friedberg
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
-
Dec 15, 2023 |
brnw.ch | Eileen M. O'Reilly |Andrew H. Ko |Jonathan W. Friedberg
THE TAKEAWAYThe trial by Burris et al1 is a landmark study not only in the realm of pancreatic cancer but also in the larger field of clinical research.
-
Nov 20, 2023 |
brnw.ch | Kara Kelly |Jonathan W. Friedberg
SUPPORTSupported in part by National Cancer Institute (R01CA262265). Conception and design: All authorsCollection and assembly of data: All authorsData analysis and interpretation: All authorsManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsClassic Hodgkin Lymphoma in Adolescents and Young AdultsThe following represents disclosure information provided by authors of this manuscript.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 2K
- DMs Open
- No
Meeting with @RepJoeMorelle office to thank him for unwavering support of @theNCI @WilmotCancer with colleagues from @RoswellPark https://t.co/WKnhAVbsTV
Great visit to Congress today with my patient Meghan to vocalize our support of @theNCI funding, which has transformed @WilmotCancer with our recent designation. @AACI_Cancer @AACR https://t.co/v8GcCqgmYP
RT @JJ_Rochester: On this #NationalClinicalTrialsDay I think of my friend, mentor and former @URMed_GCH Chief Dr. Patrick Brophy who shared…